ClinicalTrials.govpublic full text
Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis
kidney disease, chronic, diabetes, dialysis, end stage kidney disease (esrd), type 2 diabetes, semaglutide, end stage kidney disease, glp1, glp1ra, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 884153
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.